331 related articles for article (PubMed ID: 23117265)
1. The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
Karfunkel D; Carmeli Y; Chmelnitsky I; Kotlovsky T; Navon-Venezia S
Eur J Clin Microbiol Infect Dis; 2013 Apr; 32(4):513-21. PubMed ID: 23117265
[TBL] [Abstract][Full Text] [Related]
2. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
Peirano G; Costello M; Pitout JD
Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
[TBL] [Abstract][Full Text] [Related]
3. Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary Health Region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections.
Pitout JD; Gregson DB; Campbell L; Laupland KB
Antimicrob Agents Chemother; 2009 Jul; 53(7):2846-51. PubMed ID: 19380595
[TBL] [Abstract][Full Text] [Related]
4. Molecular epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15.
Park SH; Byun JH; Choi SM; Lee DG; Kim SH; Kwon JC; Park C; Choi JH; Yoo JH
BMC Infect Dis; 2012 Jun; 12():149. PubMed ID: 22747570
[TBL] [Abstract][Full Text] [Related]
5. Nationwide high prevalence of CTX-M and an increase of CTX-M-55 in Escherichia coli isolated from patients with community-onset infections in Chinese county hospitals.
Zhang J; Zheng B; Zhao L; Wei Z; Ji J; Li L; Xiao Y
BMC Infect Dis; 2014 Dec; 14():659. PubMed ID: 25466590
[TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009.
Johnson JR; Urban C; Weissman SJ; Jorgensen JH; Lewis JS; Hansen G; Edelstein PH; Robicsek A; Cleary T; Adachi J; Paterson D; Quinn J; Hanson ND; Johnston BD; Clabots C; Kuskowski MA;
Antimicrob Agents Chemother; 2012 May; 56(5):2364-70. PubMed ID: 22354301
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular epidemiology of community-onset bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli over a 6-year period.
Kang CI; Cha MK; Kim SH; Ko KS; Wi YM; Chung DR; Peck KR; Lee NY; Song JH
J Korean Med Sci; 2013 Jul; 28(7):998-1004. PubMed ID: 23853481
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan.
Komatsu Y; Kasahara K; Inoue T; Lee ST; Muratani T; Yano H; Kirita T; Mikasa K
PLoS One; 2018; 13(8):e0202276. PubMed ID: 30157275
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of CTX-M extended-spectrum beta-lactamases and sequence type 131 in Korean blood, urine, and rectal Escherichia coli isolates.
Graham SE; Zhang L; Ali I; Cho YK; Ismail MD; Carlson HA; Foxman B
Infect Genet Evol; 2016 Jul; 41():292-295. PubMed ID: 27101781
[TBL] [Abstract][Full Text] [Related]
12. CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.
Merino I; Shaw E; Horcajada JP; Cercenado E; Mirelis B; Pallarés MA; Gómez J; Xercavins M; Martínez-Martínez L; De Cueto M; Cantón R; Ruiz-Garbajosa P;
J Antimicrob Chemother; 2016 Aug; 71(8):2125-30. PubMed ID: 27494832
[TBL] [Abstract][Full Text] [Related]
13. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
[TBL] [Abstract][Full Text] [Related]
14. IncI1 plasmids carrying bla(CTX-M-1) or bla(CMY-2) genes in Escherichia coli from healthy humans and animals in Tunisia.
Ben Sallem R; Ben Slama K; Rojo-Bezares B; Porres-Osante N; Jouini A; Klibi N; Boudabous A; Sáenz Y; Torres C
Microb Drug Resist; 2014 Oct; 20(5):495-500. PubMed ID: 24826863
[TBL] [Abstract][Full Text] [Related]
15. Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Mendonça N; Leitão J; Manageiro V; Ferreira E; Caniça M
Antimicrob Agents Chemother; 2007 Jun; 51(6):1946-55. PubMed ID: 17371815
[TBL] [Abstract][Full Text] [Related]
16. Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.
Birgy A; Mariani-Kurkdjian P; Bidet P; Doit C; Genel N; Courroux C; Arlet G; Bingen E
J Clin Microbiol; 2013 Jun; 51(6):1727-32. PubMed ID: 23515552
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese hospitals.
Cao X; Cavaco LM; Lv Y; Li Y; Zheng B; Wang P; Hasman H; Liu Y; Aarestrup FM
J Clin Microbiol; 2011 Jul; 49(7):2496-501. PubMed ID: 21525216
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.
Dhanji H; Doumith M; Rooney PJ; O'Leary MC; Loughrey AC; Hope R; Woodford N; Livermore DM
J Antimicrob Chemother; 2011 Feb; 66(2):297-303. PubMed ID: 21131323
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for intestinal carriage of CTX-M-type ESBLs in Enterobacteriaceae from a Thai community.
Niumsup PR; Tansawai U; Na-Udom A; Jantapalaboon D; Assawatheptawee K; Kiddee A; Romgaew T; Lamlertthon S; Walsh TR
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):69-75. PubMed ID: 28918585
[TBL] [Abstract][Full Text] [Related]
20. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage.
Hussain A; Ewers C; Nandanwar N; Guenther S; Jadhav S; Wieler LH; Ahmed N
Antimicrob Agents Chemother; 2012 Dec; 56(12):6358-65. PubMed ID: 23045357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
